ArticleThe AAPS journal2024
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection.
Mark Klitgaard Nøhr et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it